R&D · Research & Development
Pipeline programs built on cutting-edge technology platforms, with sustained global R&D investment to bring breakthrough treatments to patients
Innovation driven by cutting-edge technologies, building a diversified pipeline layout
A mature antibody discovery and optimization platform spanning tumor immunology, autoimmune and anti-infective areas, with multiple marketed antibodies.
Antibody-drug conjugate platform with efficient linker and payload development capabilities; multiple ADC programs in preclinical and clinical stages.
Developing mRNA vaccines and therapeutics, actively exploring infectious disease vaccines, tumor immunology and protein replacement for rare diseases.
Partnering with top research institutions on CAR-T and other cell therapies, while exploring gene editing for rare diseases.
Spanning the full development cycle from Phase I to registration
| Code | Therapeutic Area | Indication | Modality | Phase | Progress |
|---|---|---|---|---|---|
| NVP-201 | Oncology | EGFR-mutant NSCLC | Small molecule (4th-gen TKI) | Phase III | |
| NVP-412 | Antibiotics | Multidrug-resistant infections | Novel cephalosporin | Registration/Approved | |
| NVP-305 | Metabolism | Obesity/Type 2 diabetes | Triple agonist | Phase II | |
| NVP-508 | Hematology | Relapsed/refractory B-cell lymphoma | CAR-T cell therapy | Phase II | |
| NVP-202 | Oncology | Advanced pancreatic cancer | ADC | Phase II | |
| NVP-601 | Anti-Inflammatory | Ulcerative colitis | Anti-IL-23 mAb | Phase II | |
| NVP-701 | HPV Vaccine | Respiratory syncytial virus (RSV) | mRNA vaccine | Phase I | |
| NVP-203 | Oncology | Hepatocellular carcinoma | Bispecific antibody | Phase I | |
| NVP-509 | Hematology | Sickle cell anemia | Gene therapy | Phase I | |
| NVP-801 | Growth Hormone | Adult GHD | Long-acting GH | Phase III | |
| NVP-306 | Metabolism | NASH | Small molecule (THR-β agonist) | Phase II | |
| NVP-413 | Antibiotics | Gram-positive infections | Novel glycopeptide | Phase I |
Learn about our ongoing clinical trials and opportunities to participate
Multiple clinical trials are recruiting patients worldwide, covering oncology, metabolism, hematology and more
Find a Trial →Understand the clinical trial process, your rights and obligations, and how to participate safely
Learn More →For clinical trial questions, contact our clinical research team for professional answers
Contact Us →35 marketed products across 10 therapeutic areas, bringing health and hope to patients worldwide
Browse Products